Pharmaceuticals, Biotechnology and Life Sciences
VANCOUVER, British Columbia, March 11, 2025 (GLOBE NEWSWIRE) — Digicann Ventures Ltd. (“Digicann” or the “Company”) (CSE: DCNN) (OTCPK: AGFAD),…
Successful 2024 marked by significant clinical advancements across Oculis’ late-stage and highly differentiated clinical pipeline targeting retina (OCS-01 in diabetic…
ZUG, Switzerland, March 11, 2025 (GLOBE NEWSWIRE) — Successful 2024 marked by significant clinical advancements across Oculis’ late-stage and highly…
Raanana, Israel, March 11, 2025 (GLOBE NEWSWIRE) — Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech…
Conference Call and Webcast to be held March 20, 2025, at 8:00 a.m. Eastern TimeYARDLEY, Pa., March 11, 2025 (GLOBE…
ROCKVILLE, MD, March 11, 2025 — MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies…
Acquired ImmPACT Bio and strengthened clinical pipeline with the addition of IMPT-314, a next-generation dual-targeting CD19/CD20 CAR T-cell product candidate…
FORT WORTH, TX, March 11, 2025 (GLOBE NEWSWIRE) — Sanara MedTech Inc. (“Sanara,” or the “Company”) (Nasdaq: SMTI), a medical…
Increased Product Sales to $133 Million in 2024Generated Pre-tax Operating Income and Net Income of $70 Million and $59 Million,…
– Company generated quarterly sequential growth in YCANTH® dispensed applicator units of 12.3% in Q4’24 concurrent with significantly lower operating…